Since FNIII14 markedly decreased the intracellular levels of N-Myc in aggressive neuroblastoma cells and remarkably reduced the cancer-associated malignant properties, FNIII14-induced β1-integrin inactivation could be considered to be functional for the targeting of N-Myc oncoprotein. This evidence concerns the gene MYCN and neuroblastoma.